Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, Gabapentin and Their Combination on Postoperative Analgesia in MRM
NCT06354478Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and gabapentin in postoperative pain (3 arms), sponsored by National Cancer Institute. Primary endpoint: Time to first rescue analgesia at 24 hours. Started Jan 2021; status: completed.
02
Drugs
dexmedetomidinegabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06354478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06354478.